Since its inception, the activities of the Institute for
Viral Pathogenesis have been, and will continue to be,
characterizing new human viral pathogens including, but not
limited to, the human herpesviruses, in particular, human
herpesvirus six (HHV-6), as well as furthering our tax exempt
(501C3) status. Recent research activity at the Institute has
focused on the role of HHV-6 in multiple sclerosis.
The Institute for Viral Pathogenesis (IVP) located in
Milwaukee, Wisconsin, was organized and is operated
exclusively for the charitable and scientific purpose of
identifying new viral pathogens in humans and exploring the
roles of these viruses as emerging pathogens. IVP researchers
Dr. Konstance Knox and Dr. Donald Carrigan receive support in
the form of research grants from private foundations,
universities, individuals, and corporations who have an
interest in contributing to the medical and scientific
understanding of viral disease.
Dr. Knox with former US
Secretary of Health and Human Services Tommy Thompson during a visit
by Mr. Thompson to the Institute's
laboratory in Milwaukee. At the time of the visit, Mr.
Thompson was governor of Wisconsin.
Institute for Viral Pathogenesis
10437 Innovation Drive, Suite 417
Milwaukee, Wisconsin 53226
Phone: 414 774-8305